Health

A New Covid-19 Pill Could Cut Your Risk of Hospitalization or Death in Half

It’d be the first on the market!

Lily Herman

Published

on

covid-19-pill-merck
covid-19-pill-merck

There’s more good news in the fight against Covid-19: A new antiviral Covid-19 pill is up for U.S. Food and Drug Administration emergency use authorization and it could significantly decrease the number of hospitalizations and deaths caused by the coronavirus.

Pharmaceutical company Merck announced on Friday morning that it had created the first oral medicine called molnupiravir to act against Covid-19. The Merck team is clear, however, that molnupiravir isn’t a vaccine that prevents the virus from taking hold and spreading. It’s an antiviral medicine meant to be consumed after a person already has Covid-19 in order to lessen symptoms, cutting the risk of hospitalization and death in patients.

Just how effective is molnupiravir? In their trial, Merck worked with 775 participants who all had mild-to-moderate Covid-19 symptoms. They took eight pills per day of the medication for five days, and Merck says that in the experiment, it proved to halve the risk of hospitalization and death due to Covid-19. “It exceeded what I thought the drug might be able to do in this clinical trial,” Dean Li, MD, PhD, vice president of Merck Research Laboratories, told Reuters. “When you see a 50 percent reduction in hospitalization or death, that’s a substantial clinical impact.”

Currently, there’s only one approved antiviral medication for Covid-19 patients called remdesivir, but because it needs to be administered via intravenous injection, it’s not as accessible to the greater population. There are three additional approved antibody therapies healthcare professionals are using to strength the immune system in Covid-19 patients, but again, those all require an IV.

While the news is exciting, there are still a few more steps involved in the process before the Covid-19 pill can enter the market, starting with Merck submitting their findings and medication to the FDA for emergency use. We hope there’s going to be more good news on this front shortly!

Trending News

Fashion5 days ago

Valerie Bertinelli, 66, Looks Like She’s ‘Aging Backwards’ as She Shows Off Her Fit Figure

TV News5 days ago

Sheinelle Jones Absent From Part of ‘Today’ Broadcast, Leaving Carson Daly to Fill in at the Last-Minute

Health4 days ago

Woman Who Undergoes 16 Pelvic Exams a Day Shares Surprising Message for Women Afraid of Pap Smears

Health6 days ago

Colin Farrell Admits He Doesn’t Know ‘Depth or Nuance’ of Son James’ Struggles With Rare Genetic Disorder

Health6 days ago

Montana Man Donated 480 Acres of Land Worth $1M in His Will to Help Advance Alzheimer’s Research

Health6 days ago

Joe Biden Says He Wouldn’t Have Gone Forward With Presidential Campaign If He’d ‘Known’ He Has Cancer

Holidays5 days ago

Joanna Gaines Reminds Us the Most Meaningful Holiday Moments Aren’t Always Picture-Perfect

HEALTH/SCIENCE5 days ago

What Men Over 50 Need to Know About the New Prostate Cancer Screening Guidelines

Sarah Paulson Sarah Paulson
Beauty5 days ago

Sarah Paulson Addresses Online Speculation She’s Had ‘Everything’ Done to Her Face

Celebrity Dads4 days ago

John Travolta Reveals He Can ‘Leave This Lifetime’ Proud of His Family With Late Wife Kelly Preston

Real Estate4 days ago

Iconic NYC Townhouse Meg Ryan’s ‘You’ve Got Mail’ Character Lived in Hits the Market for $4 Million

Health4 days ago

Jill Biden Says Her ‘Whole Life Changed’ After Joe Biden’s Cancer Diagnosis, Admits It’s ‘Hard’